Tekmira Pharmaceuticals this week announced that it has completed the public offering of $30 million of its common stock.
Through the transaction, Tekmira sold 3.75 million shares at $8 apiece. The underwriters of the offering have a 30-day option to purchase an additional 15 percent of the shares to cover over-allotments.
Tekmira stock was selling for around $8.68 during midday trading on Wednesday.